Risk of pneumonia in patients with COPD initiating fixed dose inhaled corticosteroid (ICS) / long-acting bronchodilator (LABD) formulations containing extrafine beclometasone dipropionate versus patients initiating LABD without ICS
Date
2024-01-20
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Price, D, Henley, W, Delfini Cançado, J E, Fabbri, L M, Kerstjens, H AM, Papi, A, Roche, N, Şen, E, Singh, D, Vogelmeier, C F, Nudo, E, Carter, V, Skinner, D, Vella, R, Soriano, J B, Kots, M & Georges, G 2024, 'Risk of pneumonia in patients with COPD initiating fixed dose inhaled corticosteroid (ICS) / long-acting bronchodilator (LABD) formulations containing extrafine beclometasone dipropionate versus patients initiating LABD without ICS', Pragmatic and Observational Research, vol. 15, pp. 1-16. https://doi.org/10.2147/POR.S438031